Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
Condition(s):Primary Biliary CholangitisLast Updated:March 6, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Primary Biliary CholangitisLast Updated:March 6, 2023Recruiting
Condition(s):Coronary Artery Disease; Diabetes Mellitus; Renal Insufficiency, ChronicLast Updated:November 25, 2014Completed
Condition(s):Ovarian Cancer; Prostate CancerLast Updated:March 4, 2024Recruiting
Condition(s):PBCLast Updated:February 27, 2023Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:March 27, 2024Completed
Condition(s):HIV Infections; Hepatitis CLast Updated:July 21, 2011Unknown status
Condition(s):Liver DysfunctionLast Updated:March 30, 2018Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:November 29, 2022Completed
Condition(s):Liver DiseaseLast Updated:August 9, 2021Completed
Condition(s):Healthy Study Participants; Impaired Hepatic FunctionLast Updated:July 28, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.